Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Acurio, Jesenia ^a   Troncoso, Felipe ^a   Bertoglia, Patricio ^a,b   Salomon, Carlos ^c   Aguayo, Claudio ^d   Sobrevia, Luis ^c,e   Escudero, Carlos ^a  

^a UNIVERSIDAD DEL BÍO BÍO   (Chile)

^b Obstetric and Gynecology Department   (Chile)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF CONCEPCIÓN   (Chile)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2B RECEPTOR; BETA ACTIN; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N(G) NITROARGININE METHYL ESTER; NITRITE; VASCULOTROPIN; ACETAMIDE DERIVATIVE; ANTINEOPLASTIC AGENT; N-(4-CYANOPHENYL)-2-(4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H-PURIN-8-YL)-PHENOXY)ACETAMIDE; NITRIC OXIDE; PURINE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; NEWBORN; NITRATION; PREECLAMPSIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ADULT; CELL MOTION; CLINICAL TRIAL; DRUG EFFECTS; FETUS; METABOLISM; PATHOLOGY; PREGNANCY; VASCULAR ENDOTHELIUM;

ACETAMIDES; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADULT; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FEMALE; FETUS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; PURINES; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901253741     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/274507     Document Type: Article

References (58)

1. Duley L., The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology 2009 33 3 130 137 2-s2.0-65649125690 10.1053/j.semperi.2009.02.010
2. Soto E., Romero R., Kusanovic J. P., Ogge G., Hussein Y., Yeo L., Hassan S. S., Kim C. J., Chaiworapongsa T., Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. Journal of Maternal-Fetal and Neonatal Medicine 2012 25 5 498 507 2-s2.0-84859896759 10.3109/14767058.2011.591461
3. Ogge G., Chaiworapongsa T., Romero R., Hussein Y., Kusanovic J. P., Yeo L., Kim C. J., Hassan S. S., Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. Journal of Perinatal Medicine 2011 39 6 641 652 2-s2.0-80955130024 10.1515/JPM.2011.098
4. Di Paolo S., Volpe P., Grandaliano G., Stallone G., Schena A., Greco P., Resta L., Selvaggi L., Cincione R., Schena F. P., Gesualdo L., Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. Journal of Nephrology 2003 16 5 650 657 2-s2.0-1442282935 (Pubitemid 38714248)
5. Marzioni D., Tamagnone L., Capparuccia L., Marchini C., Amici A., Todros T., Bischof P., Neidhart S., Grenningloh G., Castellucci M., Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal semaphorin 3A. Developmental Dynamics 2004 231 4 839 848 2-s2.0-19944365506 10.1002/dvdy.20178 (Pubitemid 40022745)
6. Carbillon L., Uzan M., Uzan S., Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstetrical and Gynecological Survey 2000 55 9 574 581 2-s2.0-0033844689 10.1097/00006254-200009000-00023
7. Escudero C., Casanello P., Sobrevia L., Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 2008 29 9 816 825 2-s2.0-50249099855 10.1016/j.placenta.2008.06.014
8. Sobrevia E., Westermeier F., Salomn C., Arroyo P., Palacios E., Bugueño K., Santos M., Diez de Medina C., González M., Escudero C., Mate A., Vásquez C. M., Pardo F., Leiva A., Sobrevia L., Fetoplacental vascular pathophysiology in preeclampsia. Recent Research Developments in Physiology 2012 1 Kerala, India Research Signpost 105 158
9. Roberts J. M., Taylor R. N., Musci T. J., Rodgers G. M., Hubel C. A., McLaughlin M. K., Preeclampsia: an endothelial cell disorder. American Journal of Obstetrics and Gynecology 1989 161 5 1200 1204 2-s2.0-0024398644 (Pubitemid 20007682)
10. Roberts J. M., Taylor R. N., Goldfien A., Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. American Journal of Hypertension 1991 4 8 700 708 2-s2.0-0025861266
11. Staff A. C., Braekke K., Harsem N. K., Lyberg T., Holthe M. R., Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. European Journal of Obstetrics Gynecology and Reproductive Biology 2005 122 1 33 39 2-s2.0-24644473695 10.1016/j.ejogrb.2004.11.015 (Pubitemid 41265677)
12. Myatt L., Role of placenta in preeclampsia. Endocrine 2002 19 1 103 111 2-s2.0-0036822281 10.1385/ENDO:19:1:103 (Pubitemid 36106256)
13. Kvehaugen A. S., Dechend R., Ramstad H. B., Troisi R., Fugelseth D., Staff A. C., Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011 58 1 63 69 2-s2.0-79959746297 10.1161/HYPERTENSIONAHA.111.172387
14. Escudero C., Puebla C., Westermeier F., Sobrevia L., Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia. Current Vascular Pharmacology 2009 7 4 475 485 2-s2.0-70349653507 10.2174/157016109789043865
15. Grant M. B., Davis M. I., Caballero S., Feoktistov I., Biaggioni I., Belardinelli L., Proliferation, migration, and ERK activation in human retinal endothelial cells through A2B adenosine receptor stimulation. Investigative Ophthalmology and Visual Science 2001 42 9 2068 2073 2-s2.0-0034903452 (Pubitemid 32726041)
16. Olah M. E., Stiles G. L., The role of receptor structure in determining adenosine receptor activity. Pharmacology and Therapeutics 2000 85 2 55 75 2-s2.0-0033971607 10.1016/S0163-7258(99)00051-0 (Pubitemid 30069477)
17. Jacobson K. A., Gao Z., Adenosine receptors as therapeutic targets. Nature Reviews Drug Discovery 2006 5 3 247 264 2-s2.0-33644770260 10.1038/nrd1983 (Pubitemid 43336037)
18. Fredholm B. B., Ijzerman A. P., Jacobson K. A., Klotz K.-N., Linden J., International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 2001 53 4 527 552 2-s2.0-0035209620 (Pubitemid 33136237)
19. Yoneyama Y., Sawa R., Suzuki S., Shin S., Power G. G., Araki T., The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. American Journal of Obstetrics and Gynecology 1996 174 1, part 1 267 271 2-s2.0-0030068174 10.1016/S0002-9378(96)70406-4 (Pubitemid 26037722)
20. Espinoza J., Espinoza A. F., Power G. G., High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? American Journal of Obstetrics and Gynecology 2011 205 5 485 487 2-s2.0-80255126795 10.1016/j.ajog.2011.06.034
21. von Versen-Höynck F., Rajakumar A., Bainbridge S. A., Gallaher M. J., Roberts J. M., Powers R. W., Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta 2009 30 5 434 442 2-s2.0-65049090144 10.1016/j.placenta.2009. 02.004
22. Feoktistov I., Ryzhov S., Zhong H., Goldstein A. E., Matafonov A., Zeng D., Biaggioni I., Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 2004 44 5 649 654 2-s2.0-7244234161 10.1161/01.HYP.0000144800.21037.a5 (Pubitemid 39435234)
23. Adair T. H., Growth regulation of the vascular system: an emerging role for adenosine. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005 289 2 R283 R296 2-s2.0-23044510839 10.1152/ajpregu.00840.2004 (Pubitemid 41060476)
24. Koch S., Claesson-Welsh L., Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harbor Perspectives in Medicine 2011 437 2 169 183 10. 1042/BJ20110301
25. Maynard S. E., Karumanchi S. A., Angiogenic factors and preeclampsia. Seminars in Nephrology 2011 31 1 33 46 2-s2.0-78751682439 10.1016/j.semnephrol. 2010.10.004
26. Poniedzialek-Czajkowska E., Marciniak B., Kimber-Trojnar Z., Leszczyńska-Gorzelak B., Oleszczuk J., Nitric oxide in normal and preeclamptic pregnancy. Current Pharmaceutical Biotechnology 2011 12 5 743 749 2-s2.0-79955590400
27. Wyatt A. W., Steinert J. R., Wheeler-Jones C. P. D., Morgan A. J., Sugden D., Pearson J. D., Sobrevia L., Mann G. E., Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB Journal 2002 16 12 1584 1594 2-s2.0-0036793564 10.1096/fj.01-0125com (Pubitemid 35154641)
28. Dubey R. K., Gillespie D. G., Jackson E. K., A2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 2002 39 2, part 2 530 535 2-s2.0-0036176332 10.1161/hy0202.103075 (Pubitemid 34165178)
29. Escudero C., Bertoglia P., Hernadez M., Celis C., Gonzalez M., Aguayo C., Acurio J., Impaired A(2A) adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia. Purinergic Signalling 2013 9 2 215 226 10.1007/s11302-012-9341-4
30. González P R., Gómez M R., Castro S R., Nien J. K., Merino O P., Etchegaray B A., Carstens R M., Medina H L., Viviani G P., Rojas T I., A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000. Revista Medica de Chile 2004 132 10 1155 1165 2-s2.0-19944434169
31. Casanello P., Torres A., Sanhueza F., González M., Farías M., Gallardo V., Pastor-Anglada M., San Martín R., Sobrevia L., Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circulation Research 2005 97 1 16 24 2-s2.0-22144464451 10.1161/01.RES.0000172568.49367.f8 (Pubitemid 40982318)
32. Rey S., Del Rio R., Iturriaga R., Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Brain Research 2006 1086 1 152 159 2-s2.0-33646197944 10.1016/j.brainres.2006.02.082
33. Khong T. Y., De Wolf F., Robertson W. B., Brosens I., Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. British Journal of Obstetrics and Gynaecology 1986 93 10 1049 1059 2-s2.0-0022514874 (Pubitemid 16004866)
34. Roberts J. M., Hubel C. A., The two stage model of preeclampsia: variations on the theme. Placenta 2009 30 32 37 2-s2.0-60249089098 10.1016/j.placenta.2008.11.009
35. Burton G. J., Woods A. W., Jauniaux E., Kingdom J. C. P., Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009 30 6 473 482 2-s2.0-67349192531 10.1016/j.placenta.2009.02.009
36. Myatt L., Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010 31 S66 S69 2-s2.0-76749110706 10.1016/j.placenta.2009.12.021
37. Myatt L., Cui X., Oxidative stress in the placenta. Histochemistry and Cell Biology 2004 122 4 369 382 2-s2.0-7244234849 10.1007/s00418-004-0677-x (Pubitemid 39506594)
38. Escudero C., Sobrevia L., A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008 29 6 469 483 2-s2.0-44149093091 10.1016/j.placenta.2008.02.008
39. Feoktistov I., Biaggioni I., Cronstein B. N., Adenosine receptors in wound healing, fibrosis and angiogenesis. Handbook of Experimental Pharmacology 2009 193 383 397 2-s2.0-70349303795 10.1007/978-3-540-89615-9-13
40. Grant M. B., Tarnuzzer R. W., Caballero S., Ozeck M. J., Davis M. I., Spoerri P. E., Feoktistov I., Biaggioni I., Shryock J. C., Belardinelli L., Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circulation Research 1999 85 8 699 706 2-s2.0-0033569861 (Pubitemid 29480810)
41. Feoktistov I., Goldstein A. E., Ryzhov S., Zeng D., Belardinelli L., Voyno-Yasenetskaya T., Biaggioni I., Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circulation Research 2002 90 5 531 538 2-s2.0-0037155773 10.1161/01.RES.0000012203.21416.14 (Pubitemid 34640902)
42. Fang Y., Olah M. E., Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). Journal of Pharmacology and Experimental Therapeutics 2007 322 3 1189 1200 2-s2.0-34548102416 10.1124/jpet.107.119933 (Pubitemid 47295788)
43. Li H., Jin S. Y., Son H. J., Seo J. H., Jeong G. B., Caffeine-induced endothelial cell death and the inhibition of angiogenesis. Anatomy & Cell Biology 2013 46 1 57 67 10.5115/acb.2013.46.1.57
44. Li J.-M., Fenton R. A., Cutler B. S., Dobson J. G. Jr., Adenosine enhances nitric oxide production by vascular endothelial cells. American Journal of Physiology-Cell Physiology 1995 269 2, part 1 C519 C523 2-s2.0-0028817441
45. Li J., Fenton R. A., Wheeler H. B., Powell C. C., Peyton B. D., Cutler B. S., Dobson J. G. Jr., Adenosine A(2a) receptors increase arterial endothelial cell nritric oxide. Journal of Surgical Research 1998 80 2 357 364 2-s2.0-0032217103 10.1006/jsre.1998.5439 (Pubitemid 29019694)
46. Sobrevia L., Nadal A., Yudilevich D. L., Mann G. E., Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. Journal of Physiology 1996 490 part 3 775 781 2-s2.0-0029670597
47. Vásquez G., Sanhueza F., Vásquez R., González M., San Martín R., Casanello P., Sobrevia L., Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. Journal of Physiology 2004 560 part 1 111 122 2-s2.0-6444227946 10.1113/jphysiol.2004.068288 (Pubitemid 39406020)
48. George E. M., Cockrell K., Adair T. H., Granger J. P., Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2010 299 6 R1629 R1633 2-s2.0-78649873524 10.1152/ajpregu.00330.2010
49. Gessi S., Fogli E., Sacchetto V., Merighi S., Varani K., Preti D., Leung E., MacLennan S., Borea P. A., Adenosine modulates HIF-1 α VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 1 90 97 2-s2.0-73849123855 10.1161/ATVBAHA.109.194902
50. Gu J., Ito B. R., Sartin A., Frascogna N., Moore M., Adair T. H., Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts. American Journal of Physiology-Heart and Circulatory Physiology 2000 279 5 H2116 H2123 2-s2.0-0033672176
51. Olah M. E., Roudabush F. L., Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells. Journal of Pharmacology and Experimental Therapeutics 2000 293 3 779 787 2-s2.0-0034088254 (Pubitemid 30417842)
52. Ryzhov S., McCaleb J. L., Goldstein A. E., Biaggioni I., Feoktistov I., Role of adenosine receptors in the regulation of angiogenic factors and neovascularization in hypoxia. Journal of Pharmacology and Experimental Therapeutics 2007 320 2 565 572 2-s2.0-33846407222 10.1124/jpet.106.114850 (Pubitemid 46147935)
53. Valladares D., Quezada C., Montecinos P., Concha C. I. II, Yañez A. J., Sobrevia L., Martín R. S., Adenosine A2B receptor mediates an increase on VEGF-A production in rat kidney glomeruli. Biochemical and Biophysical Research Communications 2008 366 1 180 185 2-s2.0-37449020797 10.1016/j.bbrc.2007.11.113
54. Riaño A., Ortiz-Masià D., Velázquez M., Calatayud S., Esplugues J. V., Barrachina M. D., Nitric oxide induces HIF-1 α stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. Journal of Gastroenterology 2011 46 5 565 576 2-s2.0-79958698482 10.1007/s00535-011-0374-1
55. Fredholm B. B., Irenius E., Kull B., Schulte G., Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochemical Pharmacology 2001 61 4 443 448 2-s2.0-0035865444 10.1016/S0006-2952(00)00570-0 (Pubitemid 32168226)
56. Tal R., The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biology of Reproduction 2012 87 6 134 10.1095/biolreprod.112.102723
57. Kong T., Westerman K. A., Faigle M., Eltzschig H. K., Colgan S. P., HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB Journal 2006 20 13 2242 2250 2-s2.0-33845604971 10.1096/fj.06-6419com (Pubitemid 44953854)
58. Casanello P., Krause B., Torres E., Gallardo V., González M., Prieto C., Escudero C., Farías M., Sobrevia L., Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia. Placenta 2009 30 7 625 633 2-s2.0-67449091202 10.1016/j.placenta.2009. 04.010